INSIGHTEC's Exablate Neuro Named Best Medical Technology at Esteemed Prix Galien Awards 2017

PR70767

HAIFA, Israel, Oct. 28, 2017 /PRNewswire=KYODO JBN/--

     INSIGHTEC [https://www.insightec.com ], the leader in MR-guided Focused

Ultrasound (MRgFUS), has been awarded Best Medical Technology for Exablate

Neuro by The Galien Foundation.  Exablate Neuro is an innovative medical

technology that uses focused ultrasound coupled with MR imaging (MRgFUS), to

precisely target and treat areas deep within the brain through an intact skull.

    The prestigious Prix Galien awards recognize excellence in scientific

innovations that improve the state of human health. The Best Medical Technology

award confirms INSIGHTEC's vision of transformative healthcare and the

company's determination to improve the daily lives of patients living with

essential tremor.

    "It's a great honor to receive this award, which recognizes our dedication

to researching and developing a non-invasive medical treatment," said

INSIGHTEC's CEO and Chairman of the Board, Maurice R. Ferre MD. "Our pursuit of

innovation is not only driven by our founder Kobi Vortman, but also by the

leading neurosurgery centers which have adopted the Exablate Neuro around the

world. This is an exciting time for INSIGHTEC and spurs on our commitment to

supporting healthcare professionals, deliver treatments which truly improve the

lives of people worldwide."

    Having accepted the award at The American Museum of Natural History in New

York City, INSIGHTEC's Vice President of Marketing, Xen Mendelsohn Aderka added

"To be seen as an innovator whilst in the presence of so many renowned figures

in the pharmaceutical, biomedical and medical technology industry, is a great

accolade. We thank the judges for acknowledging the hard work and dedication of

our team."

    The U.S. Food and Drug Administration (FDA) approved Exablate Neuro in July

2016 for the non-invasive treatment of patients with essential tremor who had

not responded to medication. Essential tremor is the most common movement

disorder, affecting more than 5 million people in the United States, and

millions more worldwide. Hand tremor is the most common symptom and for these

patients, performing everyday tasks can seem nearly impossible and greatly

impacts on their quality of life.

    About INSIGHTEC

    INSIGHTEC is the world leader and innovator of MR-guided Focused Ultrasound

(MRgFUS). The company's non-invasive platforms, Exablate and Exablate Neuro,

are proven technology based on sound clinical evidence for treating essential

tremor, painful bone metastases and uterine fibroids. The company is dedicated

to improving patient lives by collaborating with physicians, medical

institutions, academic researchers and regulatory bodies around the world. For

more information, please visit: http://www.insightec.com The Neuravive website

for essential tremor patients is usa.essential-tremor.com

[http://usa.essential-tremor.com ].

    Media Contact:

    Michelle Barry

    Red Lorry Yellow Lorry for INSIGHTEC

    insightec@rlyl.com

    +1-857-217-2886

    SOURCE: INSIGHTEC